Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Onto Innovation Inc ONTO

Onto Innovation Inc. is engaged in the design, development, manufacture and support of metrology and inspection tools for the semiconductor industry. The Company’s products include Automated Metrology Systems; Integrated Metrology Systems; Silicon Wafer All-surface Inspection/Characterization; Macro Defect Inspection; Automated Defect Classification and Pattern Analysis; Yield Analysis; Opaque... see more

Recent & Breaking News (NYSE:ONTO)

Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider

PR Newswire June 22, 2017

Nanobiotix : des membres du directoire procèdent à des cessions d’actions

Business Wire June 20, 2017

Nordic Nanovector to Present to Investors at the Citi European Healthcare Conference

PR Newswire Europe Non Regulatory June 19, 2017

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  June 16, 2017

NANOBIOTIX A PRESENTE DE NOUVELLES DONNEES TRANSLATIONNELLES LORS DU WORKSHOP D’IMMUNOTHERAPIE ORGANISE PAR L’ASTRO, LE NCI ET LE SITC

Business Wire June 15, 2017

Nanobiotix: New Translational Data Presented at ASTRO, NCI AND SITC’s Immunotherapy Workshop

Business Wire June 15, 2017

NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC'S Immunotherapy Workshop

GlobeNewswire June 15, 2017

Single Dose Betalutin® Continues to Show Promising Efficacy and Safety in Recurrent Indolent NHL Patients

PR Newswire June 14, 2017

Nordic Nanovector - Invitation to Conference Call for Updated Clinical Trial Results Reported at the International Conference on Malignant Lymphoma

PR Newswire Europe Non Regulatory June 13, 2017

Nordic Nanovector to be Included in Oslo Børs OBX Index

PR Newswire June 9, 2017

Accepted Abstract by ICML With Updated Results From Phase 1/2 Trial of Betalutin® in NHL is Now Available On-line

PR Newswire June 7, 2017

NANOBIOTIX : DONNEES PROMETTEUSES DE l’ESSAI DE PHASE I/II DANS LES CANCERS DE LA TETE ET DU COU AVEC NBTXR3 ; PRESENTEES AU CONGRES ANNUEL DE L’ASCO

Business Wire June 5, 2017

NANOBIOTIX : promising data from phase I/II Head and Neck cancer trial with NBTXR3 presented at the American Society of Clinical Oncology's Annual Meeting

GlobeNewswire June 5, 2017

Nordic Nanovector ASA: Allocation of Restricted Stock Units (RSUs) to the Board of Directors

PR Newswire June 2, 2017

Nordic Nanovector to Present at Jefferies Healthcare Conference in New York on Thursday, June 8th

PR Newswire June 2, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz

GlobeNewswire May 24, 2017

NANOBIOTIX : Assemblée Générale Mixte du 14 juin 2017

Business Wire May 24, 2017

Nordic Nanovector ASA: Annual General Meeting Held

PR Newswire May 24, 2017

Nordic Nanovector ASA - Results for First Quarter 2017

PR Newswire May 24, 2017

Nordic Nanovector ASA - resultater for første kvartal 2017

PR Newswire Europe Non Regulatory May 24, 2017